{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:39:36Z","timestamp":1649183976406},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.transproceed.2008.07.130","type":"journal-article","created":{"date-parts":[[2008,12,20]],"date-time":"2008-12-20T04:53:08Z","timestamp":1229748788000},"page":"3810-3812","source":"Crossref","is-referenced-by-count":2,"title":["Severe Sirolimus-Related Inflammatory State Anemia in an HIV+ Liver Transplant Patient With Calcineurin Inhibitor Renal Insufficiency: A Case Report"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"B\u00e1rcena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garc\u00eda-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Garc\u00eda-Hoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Quereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"P\u00e9rez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.07.130_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0b013e3282f37478","article-title":"Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation","volume":"22","author":"Moreno","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.transproceed.2008.07.130_bib2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.07.130_bib3","series-title":"Prognostic factors of mortality in HCV\/HIV-co-infected liver transplant recipients: the FIPSE OLT-HIV-05-GESIDA 45-05 Cohort Study","author":"Mir\u00f3","year":"2008"},{"key":"10.1016\/j.transproceed.2008.07.130_bib4","first-page":"24","article-title":"Liver transplantation in HIV\/hepatitis coinfection","volume":"12","author":"Mir\u00f3","year":"2007","journal-title":"J HIV Ther"},{"key":"10.1016\/j.transproceed.2008.07.130_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.ftd.0000245377.93401.39","article-title":"Sirolimus-challenging current perspectives","volume":"28","author":"Buhaescu","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2008.07.130_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/lt.21116","article-title":"Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients","volume":"13","author":"Morard","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2008.07.130_bib7","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.46.11.3447-3455.2002","article-title":"The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication","volume":"46","author":"Roy","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2008.07.130_bib8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1097\/QAD.0b013e3282f02a4f","article-title":"Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment","volume":"21","author":"Gilliam","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.transproceed.2008.07.130_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/lt.20031","article-title":"Post-liver transplant anemia: etiology and management","volume":"10","author":"Maheshwari","year":"2004","journal-title":"Liver Transpl"},{"issue":"3 suppl","key":"10.1016\/j.transproceed.2008.07.130_bib10","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/S0041-1345(03)00244-6","article-title":"Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience","volume":"35","author":"Morelon","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.07.130_bib11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.tp.0000179106.07382.6a","article-title":"Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state","volume":"80","author":"Thaunat","year":"2005","journal-title":"Transplantation"},{"issue":"suppl 17","key":"10.1016\/j.transproceed.2008.07.130_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1399-0012.2006.00598.x","article-title":"The role and value of sirolimus administration in kidney and liver transplantation","volume":"20","author":"Mehrabi","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2008.07.130_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jlts.2003.50119","article-title":"A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection","volume":"9","author":"Neff","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2008.07.130_bib14","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.3748\/wjg.v12.i19.3114","article-title":"Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: report of an initial experience","volume":"12","author":"Zhou","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2008.07.130_bib15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10620-005-9026-8","article-title":"Sirolimus monotherapy versus sirolimus in combination with steroids and\/or MMF for immunosuppression after liver transplantation","volume":"51","author":"Maheshwari","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2008.07.130_bib16","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/01.tp.0000262607.95372.e0","article-title":"De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects","volume":"83","author":"Toso","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.07.130_bib17","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1600-6143.2004.00612.x","article-title":"Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients","volume":"4","author":"Augustine","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2008.07.130_bib18","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.transproceed.2007.06.032","article-title":"Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients","volume":"39","author":"S\u00e1nchez Fructuoso","year":"2007","journal-title":"Transpl Proc"},{"key":"10.1016\/j.transproceed.2008.07.130_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.tp.0000235545.49391.1b","article-title":"Sirolimus interferes with iron homeostasis in renal transplant recipients","volume":"82","author":"Maiorano","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.07.130_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.07.130_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1432-2277.2005.00190.x","article-title":"Marked erythrocyte microcytosis under primary immunosuppression with sirolimus","volume":"19","author":"Kim","year":"2006","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2008.07.130_bib22","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1124\/dmd.107.016196","article-title":"Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus integrase 1 enzyme","volume":"35","author":"Kassahun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2008.07.130_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1432-2277.2007.00506.x","article-title":"Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function","volume":"20","author":"Friend","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2008.07.130_bib24","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoietin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508012499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508012499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T07:59:16Z","timestamp":1545551956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508012499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0041134508012499"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.07.130","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}